Transition from academia to industry: An interview with Elizabeth Paik
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgzox1NB6O8AbFweFE-9_zCwPpYor7qqx5wp1VrPCsC6CNI17lY08CuMB50A_HZ5l4jFBeCx_89S04Wch1-HDWSkWjNPPufR30RIaUI9sdAIhdx3zaEDEVTQccPy-V2tj-r_feA4SX8A9GE/s200/Paik%252C+Elizabeth.jpg)
We have all read many articles about the possible career choices of a scientist. The usual dilemma is between industry and academia. We have talked about this in previous blogs but the more information we get the easier it is to make a wise choice. Of course we all have opinions about the pros and cons of such a choice but what I always find best is to ask people who have experienced both. That is why I turned to an old colleague and friend, Elizabeth Paik, and asked her some questions regarding her experiences in both academia and industry. Can you describe to us your scientific career? I started my career at Harvard Medical School, as a graduate student in Dr. Len Zon's laboratory. My thesis work focused on understanding a role of CDX transcription factors during embryonic hematopoiesis. Through ChIP-seq, knockdown and overexpression studies in zebrafish, I showed CDX transcription factors control expression of hematopoietic transcription factors - SCL and LMO2. Towards the